Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review
- PMID: 28678625
- PMCID: PMC5624286
- DOI: 10.1080/19382014.2017.1335842
Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review
Abstract
Pancreatic islet transplantation is an established treatment to restore insulin independence in type 1 diabetic patients. Its success rates have increased lately based on improvements in immunosuppressive therapies and on islet isolation and culture. It is known that the quality and quantity of viable transplanted islets are crucial for the achievement of insulin independence and some studies have shown that a significant number of islets are lost during culture time. Thus, in an effort to improve islet yield during culture period, researchers have tested a variety of additives in culture media as well as alternative culture devices, such as scaffolds. However, due to the use of different categories of additives or devices, it is difficult to draw a conclusion on the benefits of these strategies. Therefore, the aim of this systematic review was to summarize the results of studies that described the use of medium additives, scaffolds or extracellular matrix (ECM) components during human pancreatic islets culture. PubMed and Embase repositories were searched. Of 5083 articles retrieved, a total of 37 articles fulfilled the eligibility criteria and were included in the review. After data extraction, articles were grouped as follows: 1) "antiapoptotic/anti-inflammatory/antioxidant," 2) "hormone," 3) "sulphonylureas," 4) "serum supplements," and 5) "scaffolds or ECM components." The effects of the reviewed additives, ECM or scaffolds on islet viability, apoptosis and function (glucose-stimulated insulin secretion - GSIS) were heterogeneous, making any major conclusion hard to sustain. Overall, some "antiapoptotic/anti-inflammatory/antioxidant" additives decreased apoptosis and improved GSIS. Moreover, islet culture with ECM components or scaffolds increased GSIS. More studies are needed to define the real impact of these strategies in improving islet transplantation outcomes.
Keywords: additives in cultures; culture of islets; extracellular matrix; human pancreatic islet; islet isolation; scaffolds.
Figures
Similar articles
-
Effect of co-culture of mesenchymal stem/stromal cells with pancreatic islets on viability and function outcomes: a systematic review and meta-analysis.Islets. 2017 Mar 4;9(2):30-42. doi: 10.1080/19382014.2017.1286434. Islets. 2017. PMID: 28151049 Free PMC article.
-
Culture on a native bone marrow-derived extracellular matrix restores the pancreatic islet basement membrane, preserves islet function, and attenuates islet immunogenicity.FASEB J. 2020 Jun;34(6):8044-8056. doi: 10.1096/fj.201902893R. Epub 2020 Apr 19. FASEB J. 2020. PMID: 32307751 Free PMC article.
-
Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Oct 18;10(10):CD007724. doi: 10.1002/14651858.CD007724.pub3. Cochrane Database Syst Rev. 2017. PMID: 29045765 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260. Health Technol Assess. 2001. PMID: 11701099
Cited by
-
In vitro generation of peri-islet basement membrane-like structures.Biomaterials. 2021 Jun;273:120808. doi: 10.1016/j.biomaterials.2021.120808. Epub 2021 Apr 13. Biomaterials. 2021. PMID: 33895491 Free PMC article.
-
Decellularization of Human Pancreatic Fragments with Pronounced Signs of Structural Changes.Int J Mol Sci. 2022 Dec 21;24(1):119. doi: 10.3390/ijms24010119. Int J Mol Sci. 2022. PMID: 36613557 Free PMC article.
-
Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.PLoS One. 2021 Jan 11;16(1):e0245204. doi: 10.1371/journal.pone.0245204. eCollection 2021. PLoS One. 2021. PMID: 33428669 Free PMC article.
-
Illuminating the complete ß-cell mass of the human pancreas- signifying a new view on the islets of Langerhans.Nat Commun. 2024 Apr 18;15(1):3318. doi: 10.1038/s41467-024-47686-7. Nat Commun. 2024. PMID: 38632302 Free PMC article.
-
Trimetazidine Preconditioning Potentiates the Effect of Mesenchymal Stem Cells Secretome on the Preservation of Rat Pancreatic Islet Survival and Function In Vitro.Appl Biochem Biotechnol. 2023 Aug;195(8):4796-4817. doi: 10.1007/s12010-023-04532-8. Epub 2023 May 15. Appl Biochem Biotechnol. 2023. PMID: 37184724
References
-
- Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54:2060-9; PMID:15983207; https://doi.org/10.2337/diabetes.54.7.2060 - DOI - PubMed
-
- Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230-8; PMID:10911004; https://doi.org/10.1056/NEJM200007273430401 - DOI - PubMed
-
- Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al.. International trial of the edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318-30; PMID:17005949; https://doi.org/10.1056/NEJMoa061267 - DOI - PubMed
-
- Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, et al.. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care 2012; 35:1436-45; PMID:22723582; https://doi.org/10.2337/dc12-0063 - DOI - PMC - PubMed
-
- Rheinheimer J, Bauer AC, Silveiro SP, Estivalet AA, Boucas AP, Rosa AR, Souza BM, Oliveira FS, Cruz LA, Brondani LA, et al.. Human pancreatic islet transplantation: An update and description of the establishment of a pancreatic islet isolation laboratory. Arch Endocrinol Metab 2015; 59:161-70; PMID:25993680; https://doi.org/10.1590/2359-3997000000030 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources